KEVIN HEALY: Open Payments
NPI 1891794673 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 19 payments from 8 companies in 2025. Trend: 2023 $737 · 2024 $565 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 2 | $182 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| PFIZER INC. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Novo Nordisk Inc | 3 | $54 |
| Ceribell, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: TERLIVAZ, ELIQUIS, LEQVIO, CAMZYOS, Ozempic, POCKET EEG DEVICE, JYNARQUE, Rybelsus.
Industry payments across MD — which companies pay providers there.
